News – Page 860 – Endpoints News

He built a MERS treatment in 6 months and then the best Ebola drug. Now Christos Kyratsous turns his sights on ...

6 years ago

As sickle cell patients find new options, NEA-founded Imara pitches mid-stage alternative for $86M IPO

6 years ago

RA joins global syndicate to back a $98M round for CANbridge

6 years ago

Drug discovery in HD: Oxford spinoff's mass spectrometry approach scores fresh funding

6 years ago

China approves flu drug being touted as a potential coronavirus treatment amid a rush of clinical studies

6 years ago

FDA goes on high alert as coronavirus raises threat to drug manufacturing and clinical trials grind to a halt

6 years ago

Warren Buffett gets a double take as the investment powerhouse settles on its first biotech investment

6 years ago

The top 100 biopharma venture investors at the megabillions deal table

6 years ago

Former Novartis exec pleads guilty to generic price fixing

6 years ago

Palleon's first CSO explains how they (and she) got here; Enterprise taps Roche and Novartis vet David Morris as CMO

6 years ago

New entries, price hikes spur changes among the 20 most expensive drugs — though not the kind politicians like to ...

6 years ago

AstraZeneca sweeps two cancer drugs to the scrap heap; Epizyme nabs priority review for second rare cancer NDA

6 years ago

If you were a cancer patient, where would you rather be — the United States or Europe?

6 years ago

AstraZeneca's Chinese investment bank partner raises $229M for its own new fund — and it's all about the ...

6 years ago

Coronavirus outbreak clouds AstraZeneca's Q4 results and 2020 outlook

6 years ago

The list of the 11 blockbusters-to-be in line for a 2020 launch highlight agony and ecstasy of drug R&D

6 years ago

Internal FDA emails reveal how price, Sanders’ pressure played a role in competitor’s approval, Catalyst claims

6 years ago

Carl June on CRISPR, CAR–T and how the Vietnam War dropped him into medicine

6 years ago

8 years after its OK, Eisai yanks its flailing obesity drug from the market after FDA flagged higher cancer rate

6 years ago

Elanco grabs $140M in deal with French pharma company; Another company announces a coronavirus vaccine hunt

6 years ago

The White House review of drug prices: Don't hate the player — hate the game

6 years ago

Seattle Genetics gets another drug close to the finish line

6 years ago

Roche scores its first PD-L1 win in China, going straight for SCLC niche

6 years ago

After FDA hold and trial failure, Ipsen writes down its big acquisition — but they're not giving up

6 years ago

First page Previous page 857 858 859860861 862 863 Next page Last page